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Infection with Helicobacter pylori cagA-positive strains is associated with gastritis, ulcerations, and gastric
cancer. CagA is translocated into infected epithelial cells by a type IV secretion system and can be tyrosine
phosphorylated, inducing signal transduction and motogenic responses in epithelial cells. Cellular cholesterol,
a vital component of the membrane, contributes to membrane dynamics and functions and is important in
VacA intoxication and phagocyte evasion during H. pylori infection. In this investigation, we showed that
cholesterol extraction by methyl--cyclodextrin reduced the level of CagA translocation and phosphorylation.
Confocal microscope visualization revealed that a significant portion of translocated CagA was colocalized with
the raft marker GM1 and c-Src during infection. Moreover, GM1 was rapidly recruited into sites of bacterial
attachment by live-cell imaging analysis. CagA and VacA were cofractionated with detergent-resistant mem-
branes (DRMs), suggesting that the distribution of CagA and VacA is associated with rafts in infected cells.
Upon cholesterol depletion, the distribution shifted to non-DRMs. Accordingly, the CagA-induced humming-
bird phenotype and interleukin-8 induction were blocked by cholesterol depletion. Raft-disrupting agents did
not influence bacterial adherence but did significantly reduce internalization activity in AGS cells. Together,
these results suggest that delivery of CagA into epithelial cells by the bacterial type IV secretion system is
mediated in a cholesterol-dependent manner.
Helicobacter pylori is a gram-negative microaerophilic gastric
pathogen that infects approximately one-half of the human
population (35, 39, 61). Persistent colonization is associated
with chronic inflammation processes, gastric atrophy, gastric
adenocarcinoma, and mucosa-associated lymphoid tissue lym-
phoma (39). Two complete genomic sequences and other re-
sults have demonstrated the unexpectedly high level of genetic
heterogeneity of this peculiar microbe and its extraordinary
ability to adapt to different ecological niches worldwide (2,
11, 55).
Virulent H. pylori strains possess a type IV secretion system
(TFSS) encoded by a cag pathogenicity island, which injects
CagA directly into infected host cells (8, 37). Translocated
CagA, after tyrosine phosphorylation by Src family kinases (37,
48), induces cell signaling, which leads to the stimulation of cell
dissemination and the “hummingbird” phenotype in gastric
epithelial cells (9, 47). Nonphosphorylated or dephosphory-
lated CagA can also be phosphorylated by Abl, a nonrecep-
tor tyrosine kinase that regulates cell morphogenesis and
motility (43). H. pylori strains with a cag pathogenicity island
have also been reported to be associated with higher levels
of interleukin-8 (IL-8) production in gastric epithelial cells
(15, 19, 22, 49, 64). Expression of CagA resulted in trans-
location of NF-B into the nucleus and activation of IL-8
transcription via a Ras-Raf-Mek-Erk-NFB signaling path-
way, which suggests that CagA is a determining factor in
inducing IL-8 release (13).
The other nonconserved virulence factor of H. pylori is an
exotoxin, vacuolating cytotoxin (VacA), which induces vacuo-
lation, alters mitochondrial membrane permeability, and in-
hibits T-cell proliferation (for a review, see reference 18).
Several types of evidence suggest that VacA intoxication relies
on cellular lipid rafts, which are dynamic microdomains con-
taining cholesterol, sphingolipids, and glycosylphosphatidyli-
nositol-anchored proteins in the exoplasmic leaflet of the lipid
bilayer and are implicated in cellular signaling, membrane
transport and trafficking, and membrane curvature (for re-
views, see references 26 and 51). First, cellular cholesterol is
required for VacA cytotoxicity in cultured gastric cells (23, 40,
46), and VacA migrates with tubulovesicular structures that
contain glycosylphosphatidylinositol-anchored proteins to en-
ter cells for its full vacuolating activity (23, 29, 44). Further-
more, using a cold detergent extraction method, VacA has
been isolated primarily on detergent-resistant membranes
(DRMs) that are generally considered to be fractions of rafts
(23, 40, 46). It has been noted that cholesterol-rich microdo-
mains are also utilized by other bacterial toxins, including
cholera toxin (38) and aerolysin (1), for entry or oligomeriza-
tion. Another role of cellular cholesterol in H. pylori infection
has recently been reported by Wunder et al.; these authors
found that H. pylori drifts toward cellular cholesterol and ab-
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sorbs it for subsequent glucosylation to evade phagocytosis
(63).
Interestingly, VacA and CagA inversely regulate the activity
of the nuclear factor of activated T cells (25). Asahi et al.
reported that translocated CagA was isolated on DRMs, in
which tyrosine-phosphorylated GIT1/Cat1 molecules, which
are substrates of the VacA receptor (receptor-type protein-
tyrosine phosphatase), were also located (5). These results
suggest that translocated CagA is raft associated and hint that
cholesterol-rich microdomains may be required for CagA de-
livery into the target cell by the TFSS. In this investigation, we
utilized AGS gastric epithelial cells, which are frequently used
as a model system, to study whether cellular cholesterol is
involved in CagA translocation and phosphorylation during H.
pylori infection. We also investigated whether depletion of
cellular cholesterol influences the CagA-induced hummingbird
phenotype and IL-8 response.
MATERIALS AND METHODS
Bacteria and cell culture. H. pylori 26695 (ATCC 700392; CagA VacA) was
used as the reference strain. Isolation, identification, and storage of H. pylori
strains were performed as described elsewhere (28, 65). The bacteria were
routinely cultured on brucella agar plates (Becton Dickinson, Franklin Lakes,
NJ) with 6 g/ml vancomycin and 2 g/ml amphotericin B in a microaerophilic
atmosphere at 37°C for 2 to 3 days. Human gastric adenocarcinoma cell line AGS
cells (CRL 1739; American Type Culture Collection, Manassas, VA) were cul-
tured in a 5% CO2 atmosphere in F-12 medium (HyClone, Logan, UT) supple-
mented with 10% decomplemented fetal bovine serum (FBS) (HyClone). No
antibiotic was used in this study.
Construction of H. pylori isogenic mutants. The isogenic mutant H. pylori
vacA::cat was generated by insertion of the cat fragment derived from pUOA20
(60) into vacA of H. pylori through allelic replacement and selection of chlor-
amphenicol-resistant clones (59). The vacA gene fragment was amplified from
the strain 62 chromosome by PCR as previously described (65) and was cloned
into plasmid pGEMT (Promega, Madison WI), yielding plasmid pGEM-vacA.
The forward and reverse oligonucleotide primers designed for PCR amplification
of the cat sequence were catMfeI_F (TGCGTCAATTGGATTGAAAAGTGG)
and catMfeI_R (AGGACGCACAATTGTCGACAGAGA), respectively. These
primers introduced an MfeI site (underlined) at the 5 and 3 ends. The amplified
product was digested with MfeI and ligated into the MfeI site of pGEM-vacA to
obtain plasmid pGEM-vacA-cat with a cat gene inserted into vacA (vacA::cat). A
vacA::cat mutant was generated by transforming pGEM-vacA-cat into the pa-
rental strain H. pylori 26695 by allelic replacement and selecting chlorampheni-
col-resistant clones using the natural transformation method described by Wang
et al. (58).
To generate cagA (CagA), vacA cagA (VacACagA), and cagE (CagE)
knockout strains, similar procedures were performed using the cat cassette, the
kanamycin resistance cassette (Kmr) from pACYC177 (45), and the erythromy-
cin resistance cassette (Eryr) from pE194 (24). The primers used for PCR
amplification of Kmr from pACYC177 had an introduced NheI site (underlined)
and were forward primer KmNheI_F (GGAAGATGCGCTAGCTGATCCTTC
AAC) and reverse primer KmNheI_R (CCCGTCAAGCTAGCGTAATGCTC
TGC). The primers used for PCR amplification of Eryr from pE194 had an
introduced XbaI site (underlined) and were forward primer EryXbaI_F (CAA
TAATCTAGACCGATTGCAGTATAA) and reverse primer EryXbaI _R (GA
CATAATCGATCTAGAAAAAATAGGCACACG). Correct integration of the
antibiotic resistance cassettes into the target genes of the chromosome was
verified by PCR. Western blot analysis was performed to confirm that the inser-
tion of cassettes abolished expression of VacA and/or CagA, as well as CagE.
Treatment with raft disruptors or usurpers in AGS cells. AGS cells (1  105
cells) were cultured in F-12 (HyClone) containing 10% decomplemented FBS
(HyClone) in 24-well plates for 20 h at 37°C. Cells were washed with phosphate-
buffered saline (PBS) three times and either were not treated or were treated
with the following agents for 1 h at 37°C in a serum-free F-12 medium: (i)
methyl--cyclodextrin (MCD) (1.0, 2.5, and 5.0 mM; Sigma-Aldrich), (ii) lova-
statin (10, 20, and 50 M; Sigma-Aldrich), and (iii) nystatin (50 g/ml; Sigma-
Aldrich, St. Louis, MO). To remove MCD or nystatin, cells were washed with
PBS three times and were cultured in fresh culture medium supplemented with
10 M lovastatin to inhibit cellular cholesterol biosynthesis. To restore choles-
terol, 400 g/ml of water-soluble cholesterol (Sigma-Aldrich) was added to
MCD-treated AGS cells, which were then incubated for 1 h at 37°C (16). To
observe the effects of cholera toxin subunit B (CTX-B), AGS cells were pre-
treated with CTX- (20 g/ml; Sigma-Aldrich) for 1 h and then infected with H.
pylori. The viability of AGS cells was determined by using trypan blue (Sigma-
Aldrich).
Detection of cellular cholesterol. To measure the level of cellular cholesterol,
AGS cells that were not treated or were treated with various agents (MCD,
lovastatin, or MCD, followed by cholesterol replenishment) were washed three
times with PBS, harvested, and disrupted by ultrasonication (three 10-s bursts at
room temperature). The cholesterol contents were then measured using an
Amplex Red cholesterol assay kit (Molecular Probes) as described in the man-
ufacturer’s instructions. The percentage of remaining cholesterol after pretreat-
ment with MCD or lovastatin was determined as follows: (measured fluores-
cence of treated cells obtained from a standard curve/total fluorescence of
untreated cells)  100.
Antibodies. Polyclonal rabbit anti-VacA antisera were prepared with the re-
combinant VacA protein consisting of 33 to 856 amino acids of ATCC 49503
VacA (29). The polyclonal mouse anti-BabA antibody was prepared with the
recombinant BabA protein of strain v344 (33). Mouse polyclonal anti-urease
antisera were produced against the recombinant UreA from strain 184 (65).
Rabbit and mouse anti-CagA antibodies were purchased from Austral Biologi-
cals. Goat anti-CagA, goat anti-actin, and rabbit anti-c-Src antibodies were
purchased from Santa Cruz Biotechnology. Anti-phosphotyrosine antibody
(4G10) was purchased from Upstate. Fluorescein isothiocyanate (FITC)-conju-
gated anti-rabbit, Cy5-conjugated anti-goat, and Cy5-conjugated anti-mouse an-
tibodies were purchased from Chemicon. FITC-conjugated CTX-B and Alexa
Fluor 555-conjugated CTX-B were purchased from Molecular Probes (Carlsbad,
CA), and horseradish peroxidase (HRP)-conjugated CTX-B was purchased from
Sigma-Aldrich. Anti-transferrin receptor antibody was purchased from BD Bio-
sciences. The working dilution of the mouse anti-VacA, anti-BabA, and anti-
UreA, rabbit anti-c-Src, and goat anti-CagA antibodies was 1:100; the working
dilution of the goat anti-actin antibody was 1:500. The working dilutions of all
other antibodies were those suggested by the manufacturers.
Confocal microscopic analysis of AGS cells infected with H. pylori. AGS cells
(5 105 cells) were seeded on coverslips in six-well plates and incubated for 20 h.
Cells were then washed and treated with or without 5.0 mM MCD for 1 h. After
three washes with PBS to remove MCD, fresh medium supplemented with 10
M lovastatin was added to the cells. Cells were then not treated or infected with
wild-type H. pylori at a multiplicity of infection (MOI) of 50 for 6 h. After three
washes with PBS, cells were fixed with 4% paraformaldehyde, permeabilized with
0.1% Triton X-100 for 30 min, and blocked with 3% (wt/vol) bovine serum
albumin in PBS for 1 h at room temperature. Samples were stained and observed
with a confocal laser scanning microscope (Zeiss LSM 510; Carl Zeiss, Go¨ttin-
gen, Germany) with a 100 objective (oil immersion; aperture, 1.3).
Live-cell imaging of AGS cells infected with H. pylori. AGS cells were seeded
onto coverslips (1.8 by 1.8 cm) at 37°C for overnight culture and then washed
with cold PBS three times. To label GM1, cells were mixed with FITC-conju-
gated CTX-B (5 g/ml; Sigma-Aldrich) in 0.1% bovine serum albumin in PBS,
which was followed by incubation on ice for 30 min and three washes with cold
PBS. For synchronized infection, cells were infected with H. pylori at an MOI of
50, and plates were then immediately centrifuged at 600  g for 5 min at 4°C
(referred to as a synchronized MOI of 50). Infected cells were then incubated at
37°C for 2 min and visualized with a Zeiss LSM510 META confocal laser
scanning microscope. Images of serial optical sections (1024  1024 pixels) were
obtained using a 40 C-Apochromate (Carl Zeiss) lens. Laser (488-nm) and
phase-contrast images were collected in a 15-s interval. Live-cell imaging exper-
iments were repeated independently at least twice. The images were acquired
blindly to minimize operator bias.
Immunoprecipitation. AGS cells were plated in six-well plates at a concentra-
tion of 1.5  105 cells per well and cultured overnight to obtain 80% confluence.
Cells were then washed and treated with or without the indicated concentrations
of MCD in the serum-free medium for 1 h. After three washes with PBS to
remove MCD, cells were incubated in the absence or presence of 400 g/ml of
water-soluble cholesterol at 37°C for another 1 h. Cells were then washed once
with PBS and not infected or infected with H. pylori. For synchronized infection,
cells were infected with H. pylori at an MOI of 50, and plates were then imme-
diately centrifuged at 600  g for 5 min, which was followed by incubation at
37°C for 6 h. Then cells were washed with PBS three times and lysed in ice-cold
immunoprecipitation buffer (25 mM Tris-HCl [pH 7.4], 150 mM NaCl, 5 mM
EDTA, 1% Triton X-100) with 1 mM Na3VO4, 1 mM phenylmethanesulfonyl
fluoride (Roche, Indianapolis, IN), 2 g/ml aprotinin, and 2 g/ml leupeptin.
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Cell lysates were centrifuged at 16,000  g for 30 min. The resultant supernatant
containing 1 mg of proteins was subsequently subjected to immunoprecipitation
using 10 g of rabbit anti-CagA polyclonal antibody and 100 l of protein A/G
PLUS-Agarose (Santa Cruz Biotechnology, Santa Cruz, CA) at 4	C overnight.
The precipitates were washed three times with immunoprecipitation buffer and
once with TBS buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1 mM CaCl2)
and then boiled with sodium dodecyl sulfate (SDS)-polyacrylamide gel electro-
phoresis (PAGE) sample buffer (62.5 mM Tris-HCl [pH 6.8], 2% SDS, 10%
glycerol, 0.05% brilliant blue R) at 95	C for 10 min. Immunoprecipitates were
then resolved by 6% SDS-PAGE and transferred onto polyvinylidene difluoride
membranes (Pall, East Hills, NY). The membranes were blocked with 5% skim
milk in TBS buffer containing 0.01% Tween 20 at room temperature for 1 h and
then incubated overnight with mouse anti-CagA or mouse anti-phosphotyrosine
(4G10) antibodies (dilution, 1:1,000) at 4	C. The blots were washed and then
incubated with HRP-conjugated secondary antibodies (Jackson Immuno-
Research, West Grove, PA) at a dilution of 1:3,000. The proteins of interest were
visualized by using the enhanced chemiluminescence assay (Amersham Pharma-
cia, Little Chalfont, United Kingdom) and were detected using an LAS-3000
imaging system (Fujifilm, Valhalla, NY).
Isolation and analysis of lipid rafts. AGS cells (1  106 cells) were infected
with H. pylori at a synchronized MOI of 50 at 37°C for 6 h and subsequently lysed
with ice-cold 1% Triton X-100 (Sigma-Aldrich) in TNE buffer (25 mM Tris-HCl,
150 mM NaCl, 5 mM EDTA) containing a 1:100 dilution of protease inhibitor
cocktail (Roche) on ice for 1 h. Optiprep (Axis-Shield, Dundee, United King-
dom) was added to the lysates at the bottom of an ultracentrifuge tube, and the
contents were adjusted to obtain a final Optiprep concentration of 40% in 600 l
(total volume), overlaid with 500 l of 35% Optiprep, 500 l of 30% Optiprep,
500 l of 25% Optiprep, or 500 l of 20% Optiprep, and topped with TNE buffer
containing no Optiprep. The gradients were centrifuged at 160,000  g for 18 h
at 4°C using an RPS56T rotor (Hitachi, Tokyo, Japan). Fractions were collected
from top to bottom, and proteins were precipitated with 6% trichloroacetic acid
(Sigma-Aldrich) and subjected to SDS-PAGE and immunoblot analysis.
To analyze the distribution of proteins in the fractions using ice-cold Triton
X-100 flotation experiments, aliquots of each fraction were mixed with SDS-
PAGE sample buffer, and the proteins were resolved by 6% SDS-PAGE under
denaturing conditions, followed by immunoblot analysis. After transfer onto
nitrocellulose membranes (Hybond-C extra; Amersham Pharmacia), the blots
were blocked with 5% skim milk in TBS buffer containing 0.01% Tween 20 at
room temperature for 1 h and then incubated with individual primary antibodies
(anti-transferrin receptor [1:1,000], anti-VacA [1:1,000], anti-CagA [1:1,000], and
anti-UreA [1:1,000]) at 4°C overnight. The proteins were probed with HRP-
conjugated secondary antibodies (1:3,000). To detect ganglioside GM1, 100-l
portions of the fractions collected from the Optiprep gradient were applied to a
nitrocellulose membrane in a manifold dot blot apparatus under suction. The
membrane was blocked with 5% skim milk in TBS buffer containing 0.01%
Tween 20 at room temperature for 1 h and then probed with HRP-conjugated
CTX-B (0.2 g/ml) for 1 h at room temperature. The membranes were detected
using the enhanced chemiluminescence system (Amersham Pharmacia).
Quantitative analysis of the AGS cell hummingbird phenotype. AGS cells (4 
105 cells) were cultured in 24-well plates containing F-12 medium supplemented
with 10% FBS at 37°C for 20 h. After one wash with PBS, cells were treated or
not treated with MCD, or they were treated with MCD followed by choles-
terol replenishment. MCD-treated cells were washed three times with PBS to
remove the MCD and then mixed with fresh medium supplemented with 10 M
lovastatin. Cells were then not infected or infected with the wild-type or CagA
H. pylori strain at a synchronized MOI of 100 for 6 h. The percentage of
elongated cells was determined by a blind investigator in order to determine the
numbers of cells having the hummingbird phenotype. Elongated cells were de-
fined as cells that had thin needlelike protrusions that were 
20 m long and a
typical elongated shape, as reported by Backert et al. (7). Cells that were the
normal shape or had the atypical elongated phenotype due to MCD treatment
(less than 20 m long and more sphere shaped than the H. pylori-induced cells)
were considered nonelongated cells. One hundred AGS cells from each photo-
graph were counted and evaluated. All samples were examined in triplicate in at
least three independent experiments. The data described below are the means of
three independent experiments.
IL-8 measurement. To detect IL-8 released by gastric epithelial cells during H.
pylori infection, the levels of IL-8 in supernatants from the AGS cells were
determined by an enzyme-linked immunosorbent assay (ELISA) using a sand-
wich ELISA kit (R&D Systems, Minneapolis, MN) according to the manufac-
turer’s instructions. Infection was performed using a synchronized MOI of 100.
Supernatants were collected and stored at 80°C before analysis.
Bacterial adherence and internalization assays. H. pylori adherence and in-
ternalization activity in AGS cells was investigated using a standard gentamicin
assay as previously described (32). AGS cells, not treated or pretreated with
MCD, nystatin, or CTX-B, were added to mid-logarithmic-phase bacteria at an
MOI of 50 and incubated at 37°C for 6 h. To determine the number of cell-
associated bacteria, infected cells were washed three times to remove unbound
bacteria and then lysed with distilled water for 10 min. Lysates were diluted in
PBS, plated onto brucella blood agar plates, and cultured for 4 to 5 days, after
which the CFU were counted. To determine the number of viable intracellular
bacteria, infected cells were washed three times with PBS and incubated with 100
g/ml of the membrane-impermeable antibiotic gentamicin (Sigma-Aldrich) for
1.5 h at 37°C to remove extracellular bacteria, which was followed by the same
procedures to determine the number of CFU. We counted viable epithelial cells
for normalization of the samples. The adhesion or internalization activities were
expressed as the means of at least six independent experiments performed in
duplicate.
Statistical analysis. Student’s t test was used to calculate the statistical signif-
icance of the experimental results for two groups; a P value of 0.05 was
considered significant.
RESULTS
Treatment with MCD or lovastatin extracts cellular cho-
lesterol and GM1 from rafts of AGS cells. MCD was first
evaluated to determine whether it could extract eukaryotic
cholesterol from lipid rafts of AGS cells (50). As shown in Fig.
1A, the level of cellular cholesterol was reduced with MCD
pretreatment for 1 h in a dose-dependent manner. When cells
were treated with 5.0 mM MCD, 
80% of cellular choles-
terol was extracted, which could later be restored by adding
cholesterol (Fig. 1A). We also evaluated the cellular choles-
terol level when cells were treated with lovastatin, an inhibitor
of 3-hydroxy-3-methylglutaryl coenzyme A reductase for cellu-
lar cholesterol biosynthesis (21). As shown in Fig. 1A, lova-
statin-treated cells contained progressively lower levels of cel-
lular cholesterol as the concentration of lovastatin increased.
On the other hand, cells remained essentially viable even when
they were treated with 5.0 mM MCD or 50 M lovastatin.
Since cholesterol, along with GM1, sphingomyelin, and gly-
cosphingolipids, is a constituent of lipid rafts (14, 66), we
sought to investigate whether MCD also extracted other raft-
associated molecules, such as GM1 (36, 62), in AGS cells. The
distribution of GM1 (stained by FITC-conjugated CTX-B) was
visualized using a confocal microscope. Untreated cells exhib-
ited a punctate GM1 staining pattern (Fig. 1B), indicating that
there were distinct regions on the cell surface that were en-
riched with GM1. GM1 was also found around the perinuclear
region, where GM1 is synthesized (56) (Fig. 1B). When cells
were treated with MCD, the extent of GM1 on the cell mem-
brane was greatly reduced, indicating that MCD extracted
both the cholesterol and GM1 that were present on lipid rafts
(Fig. 1C). Similar results were obtained when lovastatin was
added to cells (data not shown).
We next visualized cells that were infected with H. pylori at
37°C for 6 h. In the absence of MCD treatment, a portion of
GM1 was mobilized to sites of bacterial attachment, as shown
in Fig. 1D to F. Notably, some adhered bacteria were essen-
tially colocalized with GM1, indicating that there was specific
recruitment of raft-associated GM1 to sites of bacterial attach-
ment (Fig. 1F). With MCD pretreatment, a few bacteria were
observed around the membrane of infected AGS cells (Fig.
1G). The amount of GM1 in the plasma membrane was greatly
reduced (Fig. 1H), similar to the results shown in Fig. 1C.
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Accordingly, the extent of GM1 colocalization with bacteria
was greatly reduced (Fig. 1I). Thus, our data demonstrated
that GM1 clustering takes place at the site of H. pylori infection
on the cell membrane.
Adhered H. pylori and translocated CagA are found in GM1-
associated regions in infected AGS cells. To visualize the dis-
tribution of CagA in infected AGS cells, the following agents
were utilized: (i) anti-CagA antibody and (ii) anti-c-Src anti-
body. Alexa Fluor 555-conjugated CTX-B was used to visualize
GM1. In noninfected AGS cells, c-Src and GM1 were observed
around the plasma membrane or near the perinuclear region
(Fig. 2A to D). Notably, a significant portion of c-Src was
colocalized with GM1 (Fig. 2D), supporting the theory that
c-Src is raft associated (20).
We next evaluated the distribution of CagA, GM1, and c-Src
when AGS cells were incubated with a cagA knockout mutant
(CagA) or a cagE knockout mutant (CagE), as CagE serves
as an ATPase in the TFSS (for a review, see reference 12). For
CagA-infected cells, there was no CagA staining, as expected
(Fig. 2E). The distribution of GM1 and c-Src (Fig. 2F to H)
was similar to that in noninfected cells (Fig. 2B to D). For
CagE-infected cells, a few adhered bacteria were seen around
the cell surface, as revealed by the presence of CagA staining
(red) (Fig. 2I). GM1 and c-Src were also distributed near the
plasma membrane and perinuclear region of infected cells
(Fig. 2J to L). In contrast, there was no CagA staining in the
cytosol. These results suggest that CagA translocation requires
a functional TFSS, consistent with previous findings (53).
When cells were infected with wild-type H. pylori at 37°C for
6 h, CagA was seen around adhered bacteria on the cell surface
(Fig. 2M). CagA was also observed inside the cells (Fig. 2 M),
indicating that CagA was translocated into AGS cells. The
distribution of GM1 and c-Src in infected cells was similar to
that in noninfected cells, but there were more pronounced
scattered aggregates (Fig. 2N and P). In accordance with the
results shown in Fig. 1F, adhered bacteria were essentially
colocalized at sites in the GM1-associated region, as shown in
the merged CagA/GM1 image (Fig. 2Q). For translocated
CagA, a significant portion of signals was found at sites where
GM1 (Fig. 2Q) and c-Src (Fig. 2R) were colocalized. These
data suggest that during infection adhered bacteria and a great
portion of the translocated CagA were associated with mem-
branes that contained GM1 and c-Src.
Confocal microscopy live-cell imaging was performed to vi-
sualize the distribution of GM1 around adhered bacteria in
infected cells during the infection process. Cells were stained
with FITC-conjugated CTX-B to label GM1 at 4°C, which was
followed by synchronized infection at 4°C to ensure minimal
membrane fluidity. After incubation at 37°C for 2 min, infected
cells were quickly inspected to identify a region containing
adhered bacteria (this process took 5 to 10 min) for subsequent
time-lapse experiments (a 15-s series). As shown in Fig. 3A, the
first image (zero time) showed that there was a bright GM1
signal around an adhered bacterium in the region of interest
(ROI). At later times, accumulated GM1 signals were ob-
served in the ROI (Fig. 3B). Notably, a small piece of a signal
that was located at the right of the bacterium at zero time
migrated gradually toward the bacterium and finally merged
into it at 20 min (Fig. 3A, top panel). These results suggest that
raft-associated GM1 was rapidly recruited to sites of bacterial
attachment after the initial contact (within approximately 15
min) and continued mobilizing to these sites at later times.
Cholesterol extraction from infected AGS cells results in the
displacement of CagA and VacA from DRMs to non-DRMs.
After visualization of colocalization of adhered bacteria and
CagA with raft-associated molecules (GM1) using the confocal
FIG. 1. The level of cellular cholesterol and GM1 was reduced
when AGS cells were treated with MCD or lovastatin. (A) Choles-
terol levels of AGS cells treated with MCD or lovastatin. AGS cells
were treated as follows: (i) with various concentrations of MCD (0,
1.0, 2.5, and 5.0 mM), (ii) with 5.0 mM MCD and cholesterol (400
g/ml) replenishment, and (iii) with various concentrations of lova-
statin (10, 20, and 50 M). Cells were then harvested for cholesterol
detection (bars). The cell viability was hardly influenced under these
conditions, as determined by the exclusion of trypan blue. The data are
the means  standard deviations from at least triplicate independent
experiments. Two asterisks indicate that the P value was 0.01 com-
pared to untreated controls, as determined by Student’s t test. (B to I)
Confocal microscopic analysis of noninfected and infected AGS cells.
Cells that were not treated (B) or were treated with MCD (C) were
stained with FITC-conjugated CTX-B to visualize GM1. For infection
experiments, untreated cells (D to F) or MCD-treated cells (G to I)
were infected with H. pylori strain 26695 (MOI, 50) at 37°C for 6 h.
Infected cells were fixed and then probed with specific markers for
BabA (red) (D and G) and GM1 (green) (E and H). Yellow in the
merged images indicates colocalization (F and I). Scale bar, 10 m.
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microscope, we next investigated whether CagA was present in
lipid raft microdomains during H. pylori infection by use of a
cold detergent insolubility assay, a method commonly used for
investigation of raft association (52). Samples were solubilized
in cold Triton X-100, and DRMs were isolated using OptiPrep
gradients. In untreated AGS cells (Fig. 4A), GM1 was en-
riched in DRMs in the top, lighter fractions (fractions 5 to 8),
while the transferrin receptor (Tfr), a transmembrane protein
FIG. 2. Distribution of adhered bacteria, translocated CagA, GM1, and c-Src in infected AGS cells. Untreated AGS cells (A to D), CagA-
infected cells (E to H), CagE-infected cells (I to L), and wild-type H. pylori-infected cells (M to P) were fixed and stained with goat anti-CagA,
rabbit anti-c-Src, and Alexa Fluor 555-conjugated CTX-B to visualize GM1, followed by Cy5-conjugated anti-goat and FITC-conjugated anti-rabbit
antibodies. Red, CagA; pseudored, GM1; green, c-Src. Yellow in the merged images (D, H, L, and P) indicates colocalization of GM1 and c-Src.
(M to R) AGS cells were cocultured with wild-type H. pylori at 37°C for 6 h and then fixed and stained, and this was followed by observation by
confocal fluorescence microscopy as described above. For two merged images (panels Q [CagA and GM1] and R [CagA and c-Src]), the framed
region was magnified, and the magnified images are shown in the lower right corner. Areas of colocalization of CagA and GM1 (Q) or CagA and
c-Src (R) in the cell (right) are indicated by arrowheads. The adhered H. pylori bacteria in the cell (right) are indicated by arrows. Scale bars, 10
m. Hp, not treated with H. pylori; WT Hp, treated with wild-type H. pylori.
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localized to clathrin-coated pits, was associated with heavier
fractions (fractions 11 and 12). When pure bacteria were sub-
jected to the same treatment, three virulence factors (CagA,
VacA, and urease [UreA]) appeared in heavier fractions, in-
dicating that bacteria were efficiently lysed (Fig. 4B). For in-
fected AGS cells, VacA was isolated primarily in DRM frac-
tions (Fig. 4C), consistent with the previous finding that VacA
enters epithelial cells via a raft-associated endocytic route (29,
44, 46). The major portion of CagA, interestingly, was also
present in lighter fractions, and the peak was at fraction 7 (Fig.
4D), in accordance with the findings of Asahi et al. (5). In
contrast, urease was found in non-DRM fractions. When pre-
treatment with 5.0 mM MCD was used to extract cholesterol,
the levels of VacA and CagA in the lighter fractions were
significantly reduced (Fig. 4C). Moreover, the distribution of
both proteins shifted to heavier fractions (Fig. 4D), analogous
to the pattern seen for GM1. Urease remained in the nonraft
fractions after MCD pretreatment, as observed for the trans-
ferrin receptor. Thus, in AGS cells, VacA and CagA were
primarily in DRMs, whereas urease was in non-DRMs. Upon
cholesterol depletion, the VacA and CagA shifted from DRMs
to non-DRMs.
Cholesterol depletion reduces the level of CagA transloca-
tion and phosphorylation. We next evaluated whether there
was any difference in the levels of CagA translocation into H.
pylori-infected AGS cells before and after MCD treatment.
CagA was immunoprecipitated from whole-cell lysates and
analyzed by Western blotting to quantify the amount of CagA
protein delivered into AGS cells. When cells were pretreated
with different concentrations of MCD (0 to 5.0 mM), the level
of tyrosine-phosphorylated CagA decreased in a dose-depen-
dent manner (Fig. 5A and B). Compared with nontreated cells,
there was a significantly smaller amount of tyrosine-phosphor-
ylated CagA when cells were treated with 5.0 mM MCD.
Thus, cholesterol depletion by MCD that disrupted the or-
ganization of rafts also interrupted the translocation of CagA
via the TFSS, leading to the reduced level of CagA phosphor-
ylation. Upon replenishment of cholesterol, the inhibitory ef-
fect of MCD on CagA phosphorylation was reversed (Fig. 5A
and B). Together, these results suggest that the presence of
sufficient cholesterol in lipid raft microdomains is required to
mediate the translocation of CagA by the TFSS efficiently.
Cholesterol depletion inhibits the expression of the CagA-
induced hummingbird phenotype and reduces induction of
CagA-mediated IL-8. We next tested whether cholesterol ex-
traction that blocked CagA translocation/phosphorylation also
specifically reduced CagA-induced responses by evaluating the
hummingbird phenotype of AGS cells. Approximately 35% of
AGS cells exhibited the hummingbird phenotype after infec-
tion, compared with the essentially normal-shaped untreated
cells (Fig. 6A, first row, and Fig. 6B). With MCD (1.0 to 5.0
mM) pretreatment, the proportion of elongated cells was re-
duced in a dose-dependent manner (Fig. 6A, second row, and
Fig. 6B). The proportion of elongated cells was restored by
replenishment of cholesterol (Fig. 6A and B). When cells were
infected with the CagA mutant, almost no cells developed
into the long needlelike structure (Fig. 6A), consistent with
previous results (6).
Brandt et al. previously reported that CagA expression leads
to IL-8 induction via the NF-B signaling pathway in AGS cells
(13). Thus, we sought to assess whether lower levels of cellular
cholesterol had any effect on IL-8 secretion in H. pylori-in-
fected cells. In the absence of any treatment, a significantly
higher level of IL-8 production was detected in cells infected
with wild-type H. pylori than in cells infected with H. pylori
CagA (Fig. 6C), confirming the notion that CagA mediates
IL-8 induction. When cells were treated with 10 M lovastatin
and then infected with wild-type H. pylori, there was no signif-
icant difference in the level of IL-8 induction between treated
and untreated cells. As higher concentrations of lovastatin
were added (20 and 50 M), a significant decrease in the level
of IL-8 induction was detected compared with untreated cells
(P  0.01). A similar dose-dependent reduction was seen for
cells infected with H. pylori CagA. These results suggest that
CagA-induced IL-8 secretion was blocked by cholesterol de-
pletion and that efficient CagA-independent IL-8 induction
(57) might also require an adequate amount of cholesterol.
FIG. 3. GM1 is specifically recruited to the site of H. pylori attachment. (A) AGS cells were plated on coverslips, probed with FITC-conjugated
CTX-B to visualize GM1, and then infected with H. pylori as described in Materials and Methods. Infected live cells were visualized using a Zeiss
LSM510 META confocal laser scanning microscope for time-lapse experiments. Images were taken in 15-s series for a total of 25 min. Confocal
images (488 nm) taken at different time points are shown in the top panels, while the corresponding phase-contrast images are shown in the bottom
panels. The ellipse indicates an ROI, and the arrow indicates a bacterium attached to the cell. Scale bar, 5 m. (B) The fluorescence intensity in
the ROI was evaluated for all images.
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H. pylori adherence to AGS cells is not influenced by raft-
disrupting agents. We next asked whether MCD treatment
that extracted both cholesterol and GM1 influenced the level
of H. pylori binding. When cells were treated with various
concentrations of MCD, interestingly, no significant decrease
in the adherence of H. pylori to AGS cells was observed (Fig.
7A). We also evaluated the effect by treating cells with two
other raft-disrupting agents: (i) nystatin, which complexes cho-
lesterol and alters the structure and function of glycolipid
microdomains and caveolae (4); and (ii) CTX-B, which binds
to GM1 on lipid rafts (36, 62). As shown in Fig. 7A, there was
no statistical difference in the levels of bacterial adherence
when cells were treated with these agents.
As H. pylori can internalize in AGS cells, as determined by in
vitro gentamicin assays (42), we tested whether cholesterol
depletion influenced internalization by AGS cells. With
MCD pretreatment, there was dose-dependent inhibition of
internalization of bacteria in AGS cells (P  0.01) (Fig. 7B).
Additionally, treatment with both nystatin and CTX-B resulted
in significant inhibition of H. pylori internalization (P  0.05).
Collectively, these results suggest that the initial binding of H.
pylori to AGS cells is largely independent of cellular rafts,
whereas subsequent bacterial actions, including CagA translo-
cation via the TFSS and internalization in AGS cells, require
the presence of sufficient cellular cholesterol on rafts.
We also tested whether the CagA and VacA that were
present in DRMs were engaged in the process of bacterial
internalization using the AGS cultured-cell assay. Isogenic mu-
tants (VacA, CagA, and VacACagA) were generated
from 26695 by insertional mutagenesis. In vitro gentamicin
assays revealed that each mutant had significantly reduced
internalization activity compared with the parental strain (wild
type versus VacA, P  0.03; wild type versus CagA, P 
0.001; wild type versus VacACagA, P  0.001) (Fig. 7C).
There was no statistical difference in the levels of bacterial
internalization between the CagA and VacACagA mu-
tants. Our results were in accordance with the findings in
Petersen et al., who showed that abolishing expression of VacA
or CagA led to reduced levels of H. pylori internalization ac-
tivity (42). These results were also in line with the observation
that two type I strains had higher levels of entry, but not
adherence, than a type II isolate (54). With increasing concen-
trations of MCD during pretreatment, there was a dose-
dependent reduction in the level of bacterial internalization in
AGS cells compared with the untreated cells for the parental
wild-type strain (P  0.01). Similar results were obtained for
the VacA strain. CagA and VacACagA also showed
reduced internalization activity upon MCD pretreatment.
Given the much lower internalization activity, there was less
statistical significance (Fig. 7C).
FIG. 4. The distribution of CagA and VacA in infected cells shifted
from DRMs to non-DRMs upon cholesterol depletion. (A) Infected
AGS cells were subjected to fractionation in an Optiprep density
gradient at 4°C. Each fraction was assayed for GM1 with HRP-conju-
gated CTX-B using dot blot analysis and was assayed for the trans-
ferrin receptor with anti-Tfr antibody using Western blot analysis.
(B) Pure bacteria were subjected to fractionation in an Optiprep den-
sity gradient at 4°C. Each fraction was assayed for VacA, CagA, and
UreA using Western blot analysis. (C) AGS cells were infected with H.
pylori 26695, which was followed by fractionation in an Optiprep den-
sity gradient at 4°C. For cholesterol depletion, cells were treated with
5.0 mM MCD for 1 h prior to incubation. Each fraction was assayed
for VacA, CagA, and UreA using Western blot analysis. (D) VacA
(upper panel) and CagA (lower panel) signals in each fraction from
panel C were detected and expressed as relative intensities. WT Hp,
wild-type H. pylori.
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DISCUSSION
Lipid rafts that contain cellular cholesterol have been shown
to be utilized by VacA for binding and entry, hence exhibiting
intoxication activity (23, 29, 40, 44, 46). Wunder et al. recently
reported that H. pylori absorbs cellular cholesterol and trans-
forms it into glucosylated derivatives to evade phagocytosis
during infection (63). In this investigation, we showed that the
delivery of CagA into host cells and subsequent CagA-induced
functions require sufficient cellular cholesterol during infec-
tion. Several lines of evidence support this view: (i) cholesterol
depletion reduced the level of CagA translocation and phos-
phorylation in infected cells; (ii) adhered bacteria and a sig-
nificant portion of translocated CagA were colocalized with
raft-associated molecules, GM1 and c-Src, during infection;
(iii) CagA and VacA were cofractionated with DRMs and,
upon cholesterol depletion, shifted to fractions of non-DRMs;
and (iv) cholesterol depletion blocked the CagA-induced cel-
lular responses, including the hummingbird phenotype and
IL-8 induction. Our results therefore strongly suggest that cho-
lesterol plays a significant role not only in VacA intoxication
and immune evasion but also in delivering CagA into cells to
effect actin rearrangement and other CagA-mediated re-
sponses during infection. Our data, in relation to the recent
report by Kwok et al. (30), indicate that integrins are required
for H. pylori adherence and for the TFSS to inject CagA into
the host cells. It is also noted that integrins are raft associated
(34).
Observation of the accumulation of ganglioside GM1 at the
sites of bacterial uptake in infected AGS cells revealed that
there is an intimate association between adhered/endocotysed
bacteria and lipid rafts, as these microdomains are generally
dispersed in the cell membrane. We found that bacterial ad-
herence was largely unaffected by raft disruptors, including
MCD, nystatin, and CTX-B. In contrast, subsequent bacterial
actions, including CagA translocation and bacterial internal-
ization into AGS cells, were influenced by raft-disrupting
FIG. 5. Sufficient cellular cholesterol was essential for H. pylori CagA translocation and phosphorylation. (A) AGS cells were pretreated as
follows: (i) treated with various concentrations of MCD (0, 1.0, 2.5, and 5.0 mM) and (ii) treated with 5.0 mM MCD and replenished with
cholesterol (400 g/ml). Cells were then infected with the H. pylori 26695 wild type or CagA mutant. Whole-cell lysates were immunoprecipitated
for CagA, and the immunoprecipitates were subjected to Western blot analysis. Tyrosine-phosphorylated CagA was probed using mouse
anti-phosphotyrosine antibody (4G10), and CagA was probed using mouse anti-CagA. Actin from whole-cell lysates was detected by using goat
anti-actin antibody to ensure equal loading. (B) The level of CagA phosphorylation was evaluated by densitometric analysis. The values are means
and standard deviations of four independent experiments. Statistical significance was evaluated using the paired t test (asterisk, P  0.05). Hp, H.
pylori; IP, immunoprecipitation; WB, Western blotting; Cho, cholesterol; anti-PY, anti-phosphotyrosine antibody.
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agents. Indeed, confocal fluorescence microscopy revealed the
presence of adhered bacteria with or without MCD pretreat-
ment on the cell surface, while endocytosed bacteria were
observed only without MCD pretreatment. These results thus
suggest that the initial H. pylori-AGS contacts are independent
of lipid rafts. On the other hand, CagA translocation and
phosphorylation, subsequent internalization into AGS cells,
and perhaps other processes rely on the utilization of lipid
rafts.
Our data demonstrate that a high level of host cell plasma
membrane cholesterol must be maintained on rafts for efficient
TFSS-dependent CagA translocation. One hypothesis is that
cholesterol might act as a ubiquitous eukaryotic “raft-associ-
ated receptor/coreceptor” that facilitates H. pylori recognition
of the host cell surface and influences TFSS integration into
the membrane and subsequent translocation of CagA across
the membrane. This presumably provides a prominent advan-
tage, as CagA is translocated in close proximity to the host cell
targets, like c-Src, which is concentrated within cholesterol-rich
microdomains for downstream signaling. It is also possible that
rafts can serve as a physically rigid region, ensuring the assem-
bly of a complete TFSS to inject CagA into host cells effi-
ciently.
Apart from host cellular cholesterol, other determinants
may be needed to facilitate H. pylori recognition and mobili-
zation to sites of rafts or to induce movement of raft microdo-
mains into attachment sites. Bacterial adhesion molecules,
such as BabA, bind to cell surface receptors to establish the
initial contact with host cells (27). Bacterium-associated VacA,
which itself binds to rafts independently and induces fusion of
membranes from intracellular compartments (29), may pro-
mote raft coalescence into sites of bacterial attachment. How-
ever, whether other host components are engaged in this
process and how the TFSS integrates, interacts with cholesterol-
rich microdomains, and controls effector translocation into a
region with c-Src for downstream signaling requires further
investigation.
In conclusion, in this study we obtained evidence that an
adequate amount of cellular cholesterol is crucial for efficient
TFSS-mediated CagA translocation and phosphorylation, as
well as CagA-induced responses during H. pylori infection.
Along with the utilization of cellular cholesterol for VacA
intoxication and immune evasion, our data further suggest that
H. pylori is able to exploit cellular cholesterol to gain an evo-
lutionary survival advantage. Indeed, other gastrointestinal
pathogens, including FimH-expressing Escherichia coli (10)
and Shigella (31), have a common strategy for utilizing lipid
rafts that contain cholesterol. These findings may imply that
the stomach can serve as a temporary reservoir and that some
bacteria are capable of invading the gastric epithelium and
persisting in a quiescent state under suitable conditions, such
as a high level of cellular cholesterol, and later reemerge to
initiate another round of infection (3, 41). Such mechanisms
FIG. 6. The level of cellular cholesterol influenced the CagA-in-
duced responses of infected AGS cells. (A) The hummingbird pheno-
type of infected AGS cells induced by CagA was blocked by cholesterol
depletion. AGS cells were pretreated with or without MCD, which
was followed by infection with wild-type H. pylori or the CagA mu-
tant, and then viewed by phase-contrast microscopy. MCD, without
MCD treatment; MCD, with 5.0 mM MCD treatment; Cho
recover, MCD-treated cells that were replenished with 400 g/ml
cholesterol for 1 h; WT Hp, cells infected by wild-type H. pylori;
Hp, noninfected cells; CagA, cells infected by H. pylori CagA. In
each experiment, AGS cells were added to mid-logarithmic-phase bac-
teria at a synchronized MOI of 100 and incubated at 37°C for 6 h. Scale
bar, 20 m. (B) The proportion of elongated cells was determined
from the results shown in panel A. Cho, cholesterol; Hp, H. pylori; WT,
wild type. (C) Induction of IL-8 involves CagA and host cellular cho-
lesterol. AGS cells were treated with lovastatin (0, 10, 20, and 50 M)
and infected with wild-type H. pylori (filled bars) or the CagA mutant
(open bars). After 6 h of infection, the level of IL-8 in the culture
supernatant was determined by a standard ELISA method. The data
are the means and standard deviations of at least three independent
experiments. Statistical significance was evaluated using Student’s t
test (one asterisk, P  0.05; two asterisks, P  0.01; n.s., not
significant).
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may also underlie the success of H. pylori in surviving through-
out human history in this unique niche (17).
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values are the means and standard deviations of at least six indepen-
dent experiments. Statistical significance was calculated using Stu-
dent’s t test and compared to the untreated cells in panels A and B. In
panel C, statistical significance was calculated for each isogenic mutant
by comparison to wild-type H. pylori. A statistical evaluation of the
internalization activity for infected cells before and after MCD treat-
ment was performed for the wild-type, VacA, CagA, and
VacACagA strains. One asterisk, P  0.05; two asterisks, P  0.01.
3302 LAI ET AL. INFECT. IMMUN.
 o
n
 D
ecem
ber 17, 2013 by NATIO
NAL TSING
 HUA UNIVERSITY
http://iai.asm
.org/
D
ow
nloaded from
 
regulation of erythromycin-induced drug resistance. Nucleic Acids Res.
8:6081–6097.
25. Higashi, H., K. Yokoyama, Y. Fujii, S. Ren, H. Yuasa, I. Saadat, N. Murata-
Kamiya, T. Azuma, and M. Hatakeyama. 2005. EPIYA motif is a membrane-
targeting signal of Helicobacter pylori virulence factor CagA in mammalian
cells. J. Biol. Chem. 280:23130–23137.
26. Ikonen, E. 2001. Roles of lipid rafts in membrane transport. Curr. Opin. Cell
Biol. 13:470–477.
27. Ilver, D., A. Arnqvist, J. Ogren, I. M. Frick, D. Kersulyte, E. T. Incecik, D. E.
Berg, A. Covacci, L. Engstrand, and T. Boren. 1998. Helicobacter pylori
adhesin binding fucosylated histo-blood group antigens revealed by retag-
ging. Science 279:373–377.
28. Kuo, C. H., S. K. Poon, Y. C. Su, R. Su, C. S. Chang, and W. C. Wang. 1999.
Heterogeneous Helicobacter pylori isolates from H. pylori-infected couples in
Taiwan. J. Infect. Dis. 180:2064–2068.
29. Kuo, C. H., and W. C. Wang. 2003. Binding and internalization of Helico-
bacter pylori VacA via cellular lipid rafts in epithelial cells. Biochem. Biophys.
Res. Commun. 303:640–644.
30. Kwok, T., D. Zabler, S. Urman, M. Rohde, R. Hartig, S. Wessler, R.
Misselwitz, J. Berger, N. Sewald, W. Konig, and S. Backert. 2007. Helico-
bacter exploits integrin for type IV secretion and kinase activation. Nature
449:862–866.
31. Lafont, F., G. Tran Van Nhieu, K. Hanada, P. Sansonetti, and F. G. van der
Goot. 2002. Initial steps of Shigella infection depend on the cholesterol/
sphingolipid raft-mediated CD44-IpaB interaction. EMBO J. 21:4449–4457.
32. Lai, C. H., C. H. Kuo, P. Y. Chen, S. K. Poon, C. S. Chang, and W. C. Wang.
2006. Association of antibiotic resistance and higher internalization activity
in resistant Helicobacter pylori isolates. J. Antimicrob. Chemother. 57:466–
471.
33. Lai, C. H., C. H. Kuo, Y. C. Chen, F. Y. Chao, S. K. Poon, C. S. Chang, and
W. C. Wang. 2002. High prevalence of cagA- and babA2-positive Helicobacter
pylori clinical isolates in Taiwan. J. Clin. Microbiol. 40:3860–3862.
34. Leitinger, B., and N. Hogg. 2002. The involvement of lipid rafts in the
regulation of integrin function. J. Cell Sci. 115:963–972.
35. Marshall, B. 2002. Helicobacter pylori: 20 years on. Clin. Med. 2:147–152.
36. Naroeni, A., and F. Porte. 2002. Role of cholesterol and the ganglioside GM1
in entry and short-term survival of Brucella suis in murine macrophages.
Infect. Immun. 70:1640–1644.
37. Odenbreit, S., J. Puls, B. Sedlmaier, E. Gerland, W. Fischer, and R. Haas.
2000. Translocation of Helicobacter pylori CagA into gastric epithelial cells by
type IV secretion. Science 287:1497–1500.
38. Orlandi, P. A., and P. H. Fishman. 1998. Filipin-dependent inhibition of
cholera toxin: evidence for toxin internalization and activation through
caveolae-like domains. J. Cell Biol. 141:905–915.
39. Parsonnet, J. 1998. Helicobacter pylori. Infect. Dis. Clin. N. Am. 12:185–197.
40. Patel, H. K., D. C. Willhite, R. M. Patel, D. Ye, C. L. Williams, E. M. Torres,
K. B. Marty, R. A. MacDonald, and S. R. Blanke. 2002. Plasma membrane
cholesterol modulates cellular vacuolation induced by the Helicobacter pylori
vacuolating cytotoxin. Infect. Immun. 70:4112–4123.
41. Petersen, A. M., and K. A. Krogfelt. 2003. Helicobacter pylori: an invading
microorganism? A review. FEMS Immunol. Med. Microbiol. 36:117–126.
42. Petersen, A. M., K. Sorensen, J. Blom, and K. A. Krogfelt. 2001. Reduced
intracellular survival of Helicobacter pylori vacA mutants in comparison with
their wild-types indicates the role of VacA in pathogenesis. FEMS Immunol.
Med. Microbiol. 30:103–108.
43. Poppe, M., S. M. Feller, G. Romer, and S. Wessler. 2007. Phosphorylation of
Helicobacter pylori CagA by c-Abl leads to cell motility. Oncogene 26:3462–
3472.
44. Ricci, V., A. Galmiche, A. Doye, V. Necchi, E. Solcia, and P. Boquet. 2000.
High cell sensitivity to Helicobacter pylori VacA toxin depends on a GPI-
anchored protein and is not blocked by inhibition of the clathrin-mediated
pathway of endocytosis. Mol. Biol. Cell 11:3897–3909.
45. Rose, R. E. 1988. The nucleotide sequence of pACYC177. Nucleic Acids
Res. 16:356.
46. Schraw, W., Y. Li, M. S. McClain, F. G. Van Der Goot, and T. L. Cover. 2002.
Association of Helicobacter pylori vacuolating toxin (VacA) with lipid rafts.
J. Biol. Chem. 277:34642–34650.
47. Segal, E. D., J. Cha, J. Lo, S. Falkow, and L. S. Tompkins. 1999. Altered
states: involvement of phosphorylated CagA in the induction of host cellular
growth changes by Helicobacter pylori. Proc. Natl. Acad. Sci. USA 96:14559–
14564.
48. Selbach, M., S. Moese, C. R. Hauck, T. F. Meyer, and S. Backert. 2002. Src
is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo.
J. Biol. Chem. 277:6775–6778.
49. Sharma, S. A., M. K. Tummuru, M. J. Blaser, and L. D. Kerr. 1998. Acti-
vation of IL-8 gene expression by Helicobacter pylori is regulated by tran-
scription factor nuclear factor-kappa B in gastric epithelial cells. J. Immunol.
160:2401–2407.
50. Shin, J. S., Z. Gao, and S. N. Abraham. 2000. Involvement of cellular
caveolae in bacterial entry into mast cells. Science 289:785–788.
51. Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature
387:569–572.
52. Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat.
Rev. Mol. Cell Biol. 1:31–39.
53. Stein, M., R. Rappuoli, and A. Covacci. 2000. Tyrosine phosphorylation of
the Helicobacter pylori CagA antigen after cag-driven host cell translocation.
Proc. Natl. Acad. Sci. USA 97:1263–1268.
54. Su, B., S. Johansson, M. Fallman, M. Patarroyo, M. Granstrom, and S.
Normark. 1999. Signal transduction-mediated adherence and entry of Heli-
cobacter pylori into cultured cells. Gastroenterology 117:595–604.
55. Tomb, J. F., O. White, A. R. Kerlavage, R. A. Clayton, G. G. Sutton, R. D.
Fleischmann, K. A. Ketchum, H. P. Klenk, S. Gill, B. A. Dougherty, K.
Nelson, J. Quackenbush, L. Zhou, E. F. Kirkness, S. Peterson, B. Loftus, D.
Richardson, R. Dodson, H. G. Khalak, A. Glodek, K. McKenney, L. M.
Fitzegerald, N. Lee, M. D. Adams, E. K. Hickey, D. E. Berg, J. D. Gocayne,
T. R. Utterback, J. D. Peterson, J. M. Kelley, M. D. Cotton, J. M. Weidman,
C. Fujii, C. Bowman, L. Watthey, E. Wallin, W. S. Hayes, M. Borodovsky,
P. D. Karp, H. O. Smith, C. M. Fraser, and J. C. Venter. 1997. The complete
genome sequence of the gastric pathogen Helicobacter pylori. Nature 388:
539–547.
56. van Echten, G., and K. Sandhoff. 1993. Ganglioside metabolism. Enzymol-
ogy, topology, and regulation. J. Biol. Chem. 268:5341–5344.
57. Viala, J., C. Chaput, I. G. Boneca, A. Cardona, S. E. Girardin, A. P. Moran,
R. Athman, S. Memet, M. R. Huerre, A. J. Coyle, P. S. DiStefano, P. J.
Sansonetti, A. Labigne, J. Bertin, D. J. Philpott, and R. L. Ferrero. 2004.
Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag
pathogenicity island. Nat. Immunol. 5:1166–1174.
58. Wang, W. C., K. Zinn, and P. J. Bjorkman. 1993. Expression and structural
studies of fasciclin I, an insect cell adhesion molecule. J. Biol. Chem. 268:
1448–1455.
59. Wang, Y., K. P. Roos, and D. E. Taylor. 1993. Transformation of Helicobacter
pylori by chromosomal metronidazole resistance and by a plasmid with a
selectable chloramphenicol resistance marker. J. Gen. Microbiol. 139:2485–
2493.
60. Wang, Y., and D. E. Taylor. 1990. Chloramphenicol resistance in Campy-
lobacter coli: nucleotide sequence, expression, and cloning vector construc-
tion. Gene 94:23–28.
61. Warren, J. R. 1983. Unidentified curved bacilli on gastric epithelium in active
chronic gastritis. Lancet i:1273.
62. Wolf, A. A., M. G. Jobling, S. Wimer-Mackin, M. Ferguson-Maltzman, J. L.
Madara, R. K. Holmes, and W. I. Lencer. 1998. Ganglioside structure dic-
tates signal transduction by cholera toxin and association with caveolae-like
membrane domains in polarized epithelia. J. Cell Biol. 141:917–927.
63. Wunder, C., Y. Churin, F. Winau, D. Warnecke, M. Vieth, B. Lindner, U.
Zahringer, H. J. Mollenkopf, E. Heinz, and T. F. Meyer. 2006. Cholesterol
glucosylation promotes immune evasion by Helicobacter pylori. Nat. Med.
12:1030–1038.
64. Yamaoka, Y., D. H. Kwon, and D. Y. Graham. 2000. A Mr 34,000 proinflam-
matory outer membrane protein (oipA) of Helicobacter pylori. Proc. Natl.
Acad. Sci. USA 97:7533–7538.
65. Yang, J. C., T. H. Wang, H. J. Wang, C. H. Kuo, J. T. Wang, and W. C. Wang.
1997. Genetic analysis of the cytotoxin-associated gene and the vacuolating
toxin gene in Helicobacter pylori strains isolated from Taiwanese patients.
Am. J. Gastroenterol. 92:1316–1321.
66. Zeidel, M. L. 1996. Low permeabilities of apical membranes of barrier
epithelia: what makes watertight membranes watertight? Am. J. Physiol.
271:F243–F245.
Editor: J. B. Bliska
VOL. 76, 2008 CagA TRANSLOCATION REQUIRES SUFFICIENT CHOLESTEROL 3303
 o
n
 D
ecem
ber 17, 2013 by NATIO
NAL TSING
 HUA UNIVERSITY
http://iai.asm
.org/
D
ow
nloaded from
 
